NANEXA Nanexa AB (publ)

0.9794USD9.950 SEK · STO+0.30%Mkt Cap: 190.92M USDP/E: 12.76

Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposit…

Key Statistics

Company
Market Cap190.92M USD
Enterprise Value186.65M USD
Revenue (TTM)25.71M USD
Gross Profit5.51M USD
Net Income (TTM)-1.12M USD
Revenue/Share0.14 USD
Last Price0.9794 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees17
CountrySE
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINSE0007074166
Valuation
P/E (Trailing)12.76
P/E (Forward)45.23
PEG—
EV/EBITDA12.33
EV/Revenue7.26
P/S7.42
P/B6.35
EPS (TTM)0.08 USD
EPS (Forward)0.02 USD
52W Range
0.158760% of range1.526
52W High1.526 USD
52W Low0.1587 USD
Profitability
Gross Margin154.74%
Oper. Margin56.33%
EBITDA Margin58.88%
Profit Margin-31.50%
ROE-11.22%
ROA-8.24%
ROIC-13.90%
ROCE-8.08%
Growth
Revenue Growth47670.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-143.90K USD
CapEx (TTM)2.44M USD
FCF Margin-55.74%
FCF Yield-7.51%
Net Debt-4.26M USD
Net Debt/EBITDA-0.28
Net Debt/FCF—
Balance Sheet
Debt/Equity0.02
Current Ratio13.68
Quick Ratio13.68
Book Value/Sh0.15 USD
Cash/Share0.02 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.194.94M
Float153.29M
Insiders27.24%
Institutions7.27%
Technical
SMA 500.9262 (+5.7%)
SMA 2000.5285 (+85.3%)
Beta1.44
S&P 52W Chg12.00%
Avg Vol (30d)773.07K
Avg Vol (10d)769.35K
Technical Indicators
RSI (14)49.7
MACD0.0690
MACD Signal0.1734
MACD Hist.-0.1044
BB Upper1.048 USD
BB Middle1.001 USD
BB Lower0.9541 USD
BB Width9.38%
ATR (14)0.0525 USD
Vol Ratio (20d)0.46x

About Nanexa (STO: NANEXA)

›

Nanexa (STO: NANEXA) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 17 employees.

The shares were at 9.950 SEK on 19 November 2026, up 503.8% over 52 weeks. Its 52-week range is 1.612 SEK to 15.50 SEK: the price is 35.8% below the high and 517.2% above the low.

At a market capitalisation of 1.94B SEK, it trades at 12.8 times trailing earnings and 45.2 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 48% for NANEXA.

Nanexa reports return on equity of -11.2% and an operating margin of 56.3%.

It holds more cash than debt, a net cash position of 43.32M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.